Purification of recombinant shiga-like toxin type I B subunit
- PMID: 8746629
- DOI: 10.1006/prep.1995.0008
Purification of recombinant shiga-like toxin type I B subunit
Abstract
Shiga-like toxin type I (SLT-I) is a cytotoxin produced by certain strains of Escherichia coli. SLT-I is a bipartite molecule comprised of A (SLT-IA) and B (SLT-IB) subunits. In holotoxin, five B subunits are arranged in a pentameric ring and bind to globotriaosylceramide receptors on the surface of susceptible eukaryotic cells. The SLT-IB pentamer is noncovalently associated with one A subunit that has N-glycosidase activity and ultimately causes the death of targeted cells. Using a previously described overexpression vector, plasmid SBC32, we developed a two-step procedure for the purification of biologically active recombinant SLT-IB. Periplasmic proteins were extracted from E. coli JM105(pSBC32), fractionated by ammonium sulfate precipitation, and separated by isoelectric focusing in a pH 3-10 gradient. SLT-IB was present in fractions with pH values between 5.0 and 6.0, consistent with its reported pI of 5.8. SLT-IB was purified to homogeneity in a second step by native polyacrylamide gel electrophoresis. Purified SLT-IB was characterized for biological and biochemical activity. When analyzed by native polyacrylamide gel electrophoresis, the majority of SLT-IB had an apparent molecular weight of 38,900, consistent with a pentameric subunit association. Chemical cross-linking of SLT-IB with disuccinimidyl suberate resulted in species with molecular weights corresponding to dimeric, trimeric, tetrameric, and pentameric forms of B subunit. SLT-IB was not cytotoxic to Vero cells at concentrations as high as 10 micrograms/ml and protected Vero cells from native SLT-I. Purified SLT-IB maintained its ability to associate with SLT-IA to form holotoxin that exhibited toxicity similar to native toxin.
Similar articles
-
Purification of recombinant Shiga-like toxin type I A1 fragment from Escherichia coli.Protein Expr Purif. 1994 Jun;5(3):291-5. doi: 10.1006/prep.1994.1044. Protein Expr Purif. 1994. PMID: 7950374
-
Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.Infect Immun. 1994 May;62(5):1768-75. doi: 10.1128/iai.62.5.1768-1775.1994. Infect Immun. 1994. PMID: 8168939 Free PMC article.
-
Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.J Bacteriol. 1991 Feb;173(3):1151-60. doi: 10.1128/jb.173.3.1151-1160.1991. J Bacteriol. 1991. PMID: 1991714 Free PMC article.
-
Escherichia coli cytotoxins and enterotoxins.Can J Microbiol. 1992 Jul;38(7):734-46. doi: 10.1139/m92-120. Can J Microbiol. 1992. PMID: 1393838 Review.
-
Shiga toxin: purification, structure, and function.Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S293-7. doi: 10.1093/clinids/13.supplement_4.s293. Rev Infect Dis. 1991. PMID: 2047652 Review.
Cited by
-
Antiviral activity of shiga toxin 1: suppression of bovine leukemia virus-related spontaneous lymphocyte proliferation.Infect Immun. 2000 Aug;68(8):4462-9. doi: 10.1128/IAI.68.8.4462-4469.2000. Infect Immun. 2000. PMID: 10899843 Free PMC article.
-
Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.Infect Immun. 1999 Nov;67(11):6191-3. doi: 10.1128/IAI.67.11.6191-6193.1999. Infect Immun. 1999. PMID: 10531288 Free PMC article.
-
Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.Blood. 2011 Sep 22;118(12):3392-8. doi: 10.1182/blood-2011-06-363648. Epub 2011 Aug 3. Blood. 2011. PMID: 21816831 Free PMC article.
-
Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity.Infect Immun. 1998 Nov;66(11):5252-9. doi: 10.1128/IAI.66.11.5252-5259.1998. Infect Immun. 1998. PMID: 9784530 Free PMC article.
-
Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.Infect Immun. 2005 Jul;73(7):4088-97. doi: 10.1128/IAI.73.7.4088-4097.2005. Infect Immun. 2005. PMID: 15972497 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous